HomeProducts

Products

Papaverine Base

Papaverine Base is an opium-derived alkaloid and one of the most critical pharmaceutical intermediates manufactured by Parand Darou Co. It possesses potent antispasmodic properties and serves primarily as a key precursor in the synthesis of pharmaceutical products intended for the treatment of visceral and vascular spasms. Clinical Applications By acting directly on smooth muscles, Papaverine facilitates vasodilation and reduces involuntary contractions. Beyond the management of gastrointestinal spasms, this compound is utilized...

Noroxymorphone

Noroxymorphone is a strategic, semi-synthetic opioid intermediate manufactured by Parand Darou Co. This compound serves as a critical precursor and the fundamental building block in the synthesis of life-saving opioid antagonists, including Naloxone and Naltrexone, as well as the potent analgesic derivative Nalbuphine. Pharmacological Significance Characterized by a hydroxyl group at the C-14 position and a dihydromorphinan backbone, Noroxymorphone is a pivotal substrate in chemical alkylation processes. Access to this high-purity...

Noscapine Syrup

Noscapine Syrup, marketed under the brand name pd NOSCA, is a specialized Finished Dosage Form (FDF) manufactured by Parand Darou Co. Containing 7 mg of Noscapine per 5 ml, this product is a potent non-narcotic antitussive. It acts centrally on the cough center in the medulla oblongata to effectively suppress dry, irritating coughs associated with respiratory infections, the common cold, and bronchitis. Therapeutic Advantages & Accessibility Unlike narcotic cough suppressants, pd...

Methadone Syrup

Methadone Syrup is a key Finished Dosage Form (FDF) manufactured by Parand Darou Co. Formulated with a concentration of 25 mg per 5 ml (equivalent to 5 mg/ml), this product serves as a long-acting synthetic opioid agonist. It is extensively utilized in clinical protocols for Medication-Assisted Treatment (MAT) and the management of Opioid Use Disorder (OUD), providing consistent therapeutic support for addiction rehabilitation. Regulatory Status & Clinical Administration This product is...

Oxycodone FC Tablet

Oxycodone FC Tablet is a premium Finished Dosage Form (FDF) and a potent pure opioid agonist manufactured by Parand Darou Co. Engineered for clinical efficacy, Oxycodone acts primarily on central μ-opioid receptors to deliver robust analgesic relief. It is indicated for the management and relief of moderate-to-severe pain, particularly severe post-operative recovery, trauma-induced pain, and persistent oncological (cancer) pain conditions that remain refractory to non-opioid therapeutic alternatives. Therapeutic Strengths, Appearance...
PAPAVER TO PHARMACEUTICALspot_img

Active Pharmaceutical Ingredient (API)